These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 19068404)

  • 1. The clinical epidemiology of multiple sclerosis.
    Confavreux C; Vukusic S
    Neuroimaging Clin N Am; 2008 Nov; 18(4):589-622, ix-x. PubMed ID: 19068404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The natural history of multiple sclerosis with childhood onset.
    Renoux C; Vukusic S; Confavreux C
    Clin Neurol Neurosurg; 2008 Nov; 110(9):897-904. PubMed ID: 18534742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term prognosis of multiple sclerosis in Australia.
    McLeod JG; Barnett MH; Macaskill P; Williams DB
    J Neurol Sci; 2007 May; 256(1-2):35-8. PubMed ID: 17368674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical course and prognosis of 27 patients with childhood onset multiple sclerosis in Japan.
    Shiraishi K; Higuchi Y; Ozawa K; Hao Q; Saida T
    Brain Dev; 2005 Apr; 27(3):224-7. PubMed ID: 15737705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pregnancy and multiple sclerosis.
    Houtchens MK
    Semin Neurol; 2007 Nov; 27(5):434-41. PubMed ID: 17940922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Is it possible to predict the evolution of multiple sclerosis?].
    Confavreux C; Grimaud J; Vukusic S; Moreau T
    Rev Neurol (Paris); 1998 Sep; 154(8-9):624-8. PubMed ID: 9809378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Childhood multiple sclerosis].
    Roullet E
    Rev Neurol (Paris); 1998 Sep; 154(8-9):619-22. PubMed ID: 9809377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognosis of multiple sclerosis: clinical factors predicting the late evolution for an early treatment decision.
    Bergamaschi R
    Expert Rev Neurother; 2006 Mar; 6(3):357-64. PubMed ID: 16533140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Parenthood in aspect of multiple sclerosis].
    Ciepiela L
    Przegl Lek; 2010; 67(5):397-401. PubMed ID: 20684346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disability evolution in multiple sclerosis: how to deal with missing transition times in the Markov model?
    Petiot V; Quantin C; Le Teuff G; Chavance M; Binquet C; Abrahamowicz M; Moreau T
    Neuroepidemiology; 2007; 28(1):56-64. PubMed ID: 17215588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term follow-up of benign multiple sclerosis in Hordaland County, Western Norway.
    Glad SB; Nyland HI; Aarseth JH; Riise T; Myhr KM
    Mult Scler; 2009 Aug; 15(8):942-50. PubMed ID: 19570821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic significance of cerebrospinal fluid in multiple sclerosis.
    Siritho S; Freedman MS
    J Neurol Sci; 2009 Apr; 279(1-2):21-5. PubMed ID: 19181345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Practical significance of clinical-statistical studies in multiple sclerosis].
    Firnhaber W
    Med Klin; 1971 Aug; 66(32):1079-85. PubMed ID: 5562098
    [No Abstract]   [Full Text] [Related]  

  • 14. Multiple sclerosis in childhood (a clinical and statistical study of 58 cases).
    Ghezzi A; Manara F; Marforio S; Rocca M
    Acta Neurol (Napoli); 1978; 33(2):157-69. PubMed ID: 654977
    [No Abstract]   [Full Text] [Related]  

  • 15. Making progress on the natural history of multiple sclerosis.
    Compston A
    Brain; 2006 Mar; 129(Pt 3):561-3. PubMed ID: 16477087
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of pregnancy and delivery on disease activity in multiple sclerosis.
    Whitaker JN
    N Engl J Med; 1998 Jul; 339(5):339-40. PubMed ID: 9682048
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical trials of multiple sclerosis therapies: improvements to demonstrate long-term patient benefit.
    Carroll WM
    Mult Scler; 2009 Aug; 15(8):951-8. PubMed ID: 19465446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New options for early treatment of multiple sclerosis.
    Tintoré M
    J Neurol Sci; 2009 Feb; 277 Suppl 1():S9-S11. PubMed ID: 19200870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing disability progression with the Multiple Sclerosis Functional Composite.
    Rudick RA; Polman CH; Cohen JA; Walton MK; Miller AE; Confavreux C; Lublin FD; Hutchinson M; O'Connor PW; Schwid SR; Balcer LJ; Lynn F; Panzara MA; Sandrock AW
    Mult Scler; 2009 Aug; 15(8):984-97. PubMed ID: 19667023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The history of multiple sclerosis: the changing frame of the disease over the centuries.
    Murray TJ
    J Neurol Sci; 2009 Feb; 277 Suppl 1():S3-8. PubMed ID: 19200863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.